financetom
Business
financetom
/
Business
/
Kuvare working closely with regulators looking at private credit exposure, CEO says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Kuvare working closely with regulators looking at private credit exposure, CEO says
May 6, 2026 2:19 PM

May 6 (Reuters) - Insurance giant Kuvare has worked closely with regulators and ratings agencies recently to help them understand its exposure to private credit, Kuvare CEO Dhiren Jhaveri said on Wednesday at the 2026 Milken Institute Conference in Beverly Hills, California. 

Speaking on a panel about the state of private markets on Wednesday, Jhaveri and other executives discussed the opportunities and challenges facing private credit amid the ongoing Middle East conflict and retail investors' concerns about direct lenders' exposure to software companies being disrupted by artificial intelligence.

Jhaveri said his firm welcomes recent scrutiny from regulators and ratings agencies into Kuvare's balance sheet and the rationale for deploying policyholder dollars into private credit investments.

"This is the power of having a strong, long-duration, long-term balance sheet," Jhaveri said. "We have the benefit and curse of trying to figure out how to invest $6 billion of policyholder premiums every year."

Kuvare was among a group of firms that purchased a $1.4 billion loan portfolio from private credit lender Blue Owl in February in order to address investor redemption requests at its funds. Jhaveri highlighted the returns made by Kuvare on the purchase.

Speaking on a second panel about the recent private credit stress, DoubleLine CEO Jeffrey Gundlach highlighted the risks linked to lenders' growing use of payment-in-kind, wherein a borrower adds unpaid interest to a loan's principal. He also said lenders have been overvaluing many of these loans in their marks. 

"They're not performing, but they're on the books as performing," Gundlach said. "You should be marking that loan down very significantly," he later added.

Kristofer Kraus, global co-head of asset-based finance at PIMCO, said a looming wall of maturing private credit loans to software and other businesses also poses risks to lender portfolios.

"I think in '28 and '29 is when you really begin to have some pretty material sizes that need to work their way through the system," Kraus said. "So I think that that's going to be part of that opportunity set that, I think, has become a lot more interesting as we look at direct lending and how some of these names are, frankly, going to have to be refinanced." 

DoubleLine and PIMCO did not immediately respond to requests for comment. 

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Meta Platforms Signs Solar Energy Deals With Arevon Energy
Meta Platforms Signs Solar Energy Deals With Arevon Energy
Mar 5, 2024
09:52 AM EST, 03/05/2024 (MT Newswires) -- Meta Platforms ( META ) and renewable energy developer Arevon Energy said Tuesday that they signed two long-term environmental attributes purchase agreements over the Kelso solar project in Missouri. Arevon will own and operate the Kelso solar project and the facility is expected to provide renewable energy that will support Meta's operations in...
Blackcat ransomware site claims it was seized; UK law enforcement denies being behind disruption
Blackcat ransomware site claims it was seized; UK law enforcement denies being behind disruption
Mar 5, 2024
WASHINGTON, March 5 (Reuters) - The website used by the hackers responsible for the breach at UnitedHealth Group ( UNH ) has been replaced by a notice claiming it was seized by international law enforcement. But at least one of the law enforcement agencies allegedly responsible for taking the gang down says it had nothing to do with the operation,...
Dialysis firms gain as Ozempic kidney trial data disappoints
Dialysis firms gain as Ozempic kidney trial data disappoints
Mar 5, 2024
(Reuters) - Shares of dialysis services providers jumped in early trading on Tuesday after Novo Nordisk's popular diabetes drug Ozempic fell short of some expectations when tested on patients with chronic kidney disease. Colorado-based DaVita ( DVA ) rose 7.4%, while the U.S.-listed shares of rival Fresenius Medical were up 9.5% in early trading. Baxter International ( BAX ), which...
DexCom Says Use of Automated Insulin Delivery System Reduces Hypoglycemia in Diabetes Patients
DexCom Says Use of Automated Insulin Delivery System Reduces Hypoglycemia in Diabetes Patients
Mar 5, 2024
09:54 AM EST, 03/05/2024 (MT Newswires) -- DexCom ( DXCM ) said Tuesday it has real world evidence showing that the use of its automated insulin delivery system powered by its continuous glucose monitoring, or CGM, technology can reduce severe hypoglycemia and ketoacidosis in patients with type 1 diabetes over 12 months. The company also said it has evidence showing...
Copyright 2023-2026 - www.financetom.com All Rights Reserved